Pdt Partners, LLC Clovis Oncology, Inc. Transaction History

Pdt Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.06 - $5.8 $45,719 - $65,313	-11,261 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$5.02 - $7.05 $206,497 - $290,001	-41,135 Reduced 78.51%	11,261 $65,000
Q1 2021 May 17, 2021	BUY	$4.81 - $10.34 $252,024 - $541,774	52,396 New	52,396 $368,000
Q1 2019 May 15, 2019	SELL	$17.66 - $30.28 $3.55 Million - $6.09 Million	-201,218 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$11.63 - $32.67 $2.34 Million - $6.57 Million	201,218 New	201,218 $3.61 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.